PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Chart, page-4256

  1. 4,184 Posts.
    lightbulb Created with Sketch. 6658
    Weazel and 39KP, I offer you this:


    a∝1/b


    a is our share price
    b is our potential for sales and nutty amazing future growth.

    Non mathematicians, it's inversely proportional...
    As b increases, it's like our share price goes the other way!

    Brughhhhh


    I know there is share price disconnect but this is bordering on silly.

    But I also get that no amount of science at the moment is going to lift this one..we need funding. How do we get it?

    Well as they have said in a number of recent seminars and podcasts....data data and more data.

    What that means is Phase 3...

    We have given them choice data in 008...but we need it at scale...we need durability at scale too, and that's the P3.

    I reckon our chances of finding funding increase dramatically once P3 is a GO.

    I also agree with 39KP...this can flip fairly quickly IF things work out relatively smoothly. Thats the unknown for the market...if and when.




    Last edited by Mozzarc: 18/06/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.